Building Canada’s vaccine manufacturing infrastructure, more than just walls

While having a strategy to address all aspects of vaccine manufacturing infrastructure is a positive, the key to success will be ensuring the strategy is followed and constantly refined as we progress down the path to biomanufacturing independence.

Canada's Chief Health Medical Theresa Tam, pictured April 2, 2020, on the Hill at a press conference. The Hill Times photograph by Andrew Meade

Opinion

BY TRINA RACINE

September 13, 2021

There are many opinions on who is to blame for the privatization of the government-owned Connaught Laboratories in Toronto in the 1970s and 80s and the reasons behind it. We should, however, be able to agree that these decisions and others like it resulted in Canada’s inability to react quickly to...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy